There is no shortage of investors who are bullish on The9 Limited ADR (NCTY) stock

A share price of The9 Limited ADR [NCTY] is currently trading at $6.79, up 14.12%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The NCTY shares have gain 22.12% over the last week, with a monthly amount glided 13.17%, and seem to be holding up well over a long-time horizon.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

On 26, March 2024, /C O R R E C T I O N — The9 Limited/. In a post published today on Yahoo Finance, In the news release, The9 Signed a Definitive Share Purchase Agreement to Invest in GenAI LLM Digital Precision Medicine Platform for Brain Disease WM Therapeutic, issued 26-Mar-2024 by The9 Limited over PR Newswire, we are advised by the company that the 5th paragraph, should read “As of the date hereof, the total number of issued and outstanding shares of The9 is 1,675,281,127 (equivalent to 5,584,270 ADSs), being the sum of 1,661,673,793Class A ordinary shares and 13,607,334 Class B ordinary shares.”. The complete, corrected release follows:.

From an analyst’s perspective:

The9 Limited ADR [NASDAQ: NCTY] stock has seen the most recent analyst activity on November 13, 2009, when JP Morgan downgraded its rating to a Neutral. Previously, Oppenheimer downgraded its rating to Perform on June 18, 2009. On April 16, 2009, Roth Capital reiterated its Hold rating and revised its price target to $11 on the stock. ThinkEquity reiterated its Buy rating and increased its price target to $20 on January 27, 2009. Sterne Agee initiated its recommendation with a Hold and recommended $16 as its price target on January 27, 2009. Deutsche Securities upgraded its rating to Buy for this stock on September 26, 2008. In a note dated August 08, 2008, Brean Murray downgraded an Hold rating on this stock.

The9 Limited ADR experienced fluctuations in its stock price throughout the past year between $3.33 and $14.70. The9 Limited ADR [NASDAQ: NCTY] shares were valued at $6.79 at the most recent close of the market.

Analyzing the NCTY fundamentals

Trailing Twelve Months sales for The9 Limited ADR [NASDAQ:NCTY] were 23.76M which represents 78.79% growth. Gross Profit Margin for this corporation currently stands at -0.39% with Operating Profit Margin at -2.24%, Pretax Profit Margin comes in at -4.05%, and Net Profit Margin reading is -4.02%. To continue investigating profitability, this company’s Return on Assets is posted at -1.88, Equity is 11.21 and Total Capital is 2.08. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of-0.58.

Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 6.05 points at the first support level, and at 5.30 for the second support level. However, for the 1st resistance point, the stock is sitting at 7.22, and for the 2nd resistance point, it is at 7.64.

The9 Limited ADR [NCTY] reported earnings per share of -$228 for its fiscal quarter that ended on 6/29/2012. Based on the Wall Street analysts’ estimates, the company was expected to report earnings of -$108/share, meaning a difference of -$120 and a surprise factor of -111.10%. By comparison, the stated earnings for the previous quarter ended on 3/30/2012 were -$216 per share as compared to estimates of -$252 per share, a difference of $36 representing a surprise of 14.30%.

Ratios To Look Out For

To put it in perspective, the Current Ratio for The9 Limited ADR [NASDAQ:NCTY] is 0.30. Also, the Quick Ratio is 0.30, while the Cash Ratio stands at 0.04. Considering the valuation of this stock, the price to sales ratio is 0.90.

Related Posts